Relay Therapeutics (RLAY) Earnings Date & Reports

A.I. Advisor

published Earnings

RLAY is expected to report earnings to rise 14.62% to -79 cents per share on October 31

Relay Therapeutics RLAY Stock Earnings Reports

Q3'24

Est.

$-0.79

Q2'24

Beat

by $0.04

Q1'24

Beat

by $0.12

Q4'23

Beat

by $0.05

Q3'23

Beat

by $0.29

The last earnings report on August 06 showed earnings per share of -68 cents, beating the estimate of -73 cents. With 3.46M shares outstanding, the current market capitalization sits at 1.21B.

View a ticker or compare two or three

Compare

RLAY

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For RLAY
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RLAY (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a clinical-stage precision medicines company, which focuses on using innovative experimental and computational approaches on protein motion for making medicines against intractable precision medicine targets

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

399 Binney Street

Phone

+1 617 370-8837

Employees

323

Web

https://www.relaytx.com